Yao Weng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yao Weng has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Hirohiko Okamura
Department of Oral Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan
5 shared publications Mika Ikegame
Department of Oral Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan
4 shared publications- Yuhan He
Department of Oral Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan
3 shared publications - Ziyi Wang
Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
3 shared publications Airi Tanai
Department of Oral Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kitaku, Okayama 770-8525, Japan
2 shared publications- Heriati Sitosari
Department of Oral Biology, Faculty of Dentistry, Universitas Gadjah Mada, Indonesia
2 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Wiley in BioFactors
- Vol. 52 (3) , e70104
VGLL3 Regulates DAPK2 ‐Mediated Autophagy During Osteoblast Differentiation
Vestigial‐like family member 3 (VGLL3), a transcriptional cofactor of the TEA domain family, has been previously identified as a regulator of osteoblast differentiation. Building upon our previous findings, we investigated VGLL3 function in MC3T3‐E1 osteoblasts using an integrated approach combining transcriptomic analysis and functional assays to identify its downstream effectors and explore associated autophagy mechanisms. RNA‐seq analysis of Vgll3‐knockdown (shVgll3) cells identified death‐associated protein kinase 2 (DAPK2), a regulator of autophagy, as a downstream effector. Autophagic activity was examined using transmission electron microscopy and western blot analysis of LC3‐II and p62 proteins. The effects of Dapk2 knockdown (shDapk2) on osteoblast differentiation were evaluated using qPCR, western blotting, alkaline phosphatase staining, and Alizarin Red staining. Rapamycin treatment was used to determine whether pharmacologic activation of autophagy could restore osteoblast function. Vgll3 knockdown significantly suppressed autophagic flux, as evidenced by fewer autophagic vacuoles, decreased LC3‐II accumulation, and increased p62 expression. A comparable reduction in autophagic activity was observed in shDapk2 cells and was accompanied by impaired osteoblast differentiation. Rapamycin treatment partially restored autophagy and osteogenic differentiation in Vgll3‐deficient cells. Finally, overexpression of DAPK2 partially rescued autophagic activity and osteogenic differentiation in shVgll3 cells, supporting its role as a key downstream functional effector. FOXM1 was further implicated as a potential transcriptional regulator contributing to DAPK2 expression. Collectively, our findings suggest that VGLL3 may influence osteogenic differentiation in osteoblasts, potentially involving DAPK2‐associated autophagy.
- 29 April 2026
- Published by Wiley in BioFactors
- Vol. 52 (3) , e70104
Open AccessVGLL3 Regulates DAPK2 ‐Mediated Autophagy During Osteoblast Differentiation
Vestigial‐like family member 3 (VGLL3), a transcriptional cofactor of the TEA domain family, has been previously identified as a regulator of osteoblast differentiation. Building upon our previous findings, we investigated VGLL3 function in MC3T3‐E1 osteoblasts using an integrated approach combining transcriptomic analysis and functional assays to identify its downstream effectors and explore associated autophagy mechanisms. RNA‐seq analysis of Vgll3‐knockdown (shVgll3) cells identified death‐associated protein kinase 2 (DAPK2), a regulator of autophagy, as a downstream effector. Autophagic activity was examined using transmission electron microscopy and western blot analysis of LC3‐II and p62 proteins. The effects of Dapk2 knockdown (shDapk2) on osteoblast differentiation were evaluated using qPCR, western blotting, alkaline phosphatase staining, and Alizarin Red staining. Rapamycin treatment was used to determine whether pharmacologic activation of autophagy could restore osteoblast function. Vgll3 knockdown significantly suppressed autophagic flux, as evidenced by fewer autophagic vacuoles, decreased LC3‐II accumulation, and increased p62 expression. A comparable reduction in autophagic activity was observed in shDapk2 cells and was accompanied by impaired osteoblast differentiation. Rapamycin treatment partially restored autophagy and osteogenic differentiation in Vgll3‐deficient cells. Finally, overexpression of DAPK2 partially rescued autophagic activity and osteogenic differentiation in shVgll3 cells, supporting its role as a key downstream functional effector. FOXM1 was further implicated as a potential transcriptional regulator contributing to DAPK2 expression. Collectively, our findings suggest that VGLL3 may influence osteogenic differentiation in osteoblasts, potentially involving DAPK2‐associated autophagy.
- 15 October 2024
- Published by Wiley in BioFactors
- Vol. 51 (1)
O ‐ GlcNAcylation regulates osteoblast differentiation through the morphological changes in mitochondria, cytoskeleton, and endoplasmic reticulum
To explore the potential mechanisms which O ‐linked‐N‐acetylglucosaminylation ( O ‐GlcNAcylation) regulates osteogenesis, a publicly RNA‐seq dataset was re‐analyzed with literature‐mining and showed the primary targets of O ‐GlcNAcylation in osteoblasts are mitochondria/cytoskeleton. Although the O ‐GlcNAcylation‐regulated mitochondria/cytoskeleton has been extensively studied, its specific role during osteogenesis remains unclear. To address this, we knocked out Ogt (Ogt‐KO) in MC3T3‐E1 osteoblastic cells. Then, significantly reduced osteoblast differentiation, motility, proliferation, mitochondria–endoplasmic reticulum (Mito–ER) coupling, volume of ER, nuclear tubulins, and oxygen metabolism were observed in Ogt‐KO cells. Through artificial intelligence (AI)‐predicted cellular structures, the time‐lapse live cells imaging with reactive‐oxygen‐species/hypoxia staining showed that lower cell proliferation and altered oxygen metabolism in the Ogt‐KO cells were correlated with the Mito–ER coupling. Bioinformatics analysis, combined with correlated mRNA and protein expression, suggested that Ezh2 and its downstream targets ( Opa1 , Gsk3a , Wnt3a , Hif1a , and Hspa9 ) may be involved in O ‐GlcNAcylation‐regulated Mito–ER coupling, ultimately impacting osteoblast differentiation. In conclusion, our findings indicate that O‐GlcNAcylation‐regulated osteoblast differentiation is linked to morphological changes in mitochondria, cytoskeleton, and ER, with Ezh2 potentially playing a crucial role.
- 15 October 2024
- Published by Wiley in BioFactors
- Vol. 51 (1)
O ‐ GlcNAcylation regulates osteoblast differentiation through the morphological changes in mitochondria, cytoskeleton, and endoplasmic reticulum
To explore the potential mechanisms which O ‐linked‐N‐acetylglucosaminylation ( O ‐GlcNAcylation) regulates osteogenesis, a publicly RNA‐seq dataset was re‐analyzed with literature‐mining and showed the primary targets of O ‐GlcNAcylation in osteoblasts are mitochondria/cytoskeleton. Although the O ‐GlcNAcylation‐regulated mitochondria/cytoskeleton has been extensively studied, its specific role during osteogenesis remains unclear. To address this, we knocked out Ogt (Ogt‐KO) in MC3T3‐E1 osteoblastic cells. Then, significantly reduced osteoblast differentiation, motility, proliferation, mitochondria–endoplasmic reticulum (Mito–ER) coupling, volume of ER, nuclear tubulins, and oxygen metabolism were observed in Ogt‐KO cells. Through artificial intelligence (AI)‐predicted cellular structures, the time‐lapse live cells imaging with reactive‐oxygen‐species/hypoxia staining showed that lower cell proliferation and altered oxygen metabolism in the Ogt‐KO cells were correlated with the Mito–ER coupling. Bioinformatics analysis, combined with correlated mRNA and protein expression, suggested that Ezh2 and its downstream targets ( Opa1 , Gsk3a , Wnt3a , Hif1a , and Hspa9 ) may be involved in O ‐GlcNAcylation‐regulated Mito–ER coupling, ultimately impacting osteoblast differentiation. In conclusion, our findings indicate that O‐GlcNAcylation‐regulated osteoblast differentiation is linked to morphological changes in mitochondria, cytoskeleton, and ER, with Ezh2 potentially playing a crucial role.
- Open Access
- 26 August 2021
- Published by Elsevier in Japanese Dental Science Review
- Vol. 57, 138-146
Outer membrane vesicles of Porphyromonas gingivalis: Novel communication tool and strategy
- 26 August 2021
- Published by Elsevier in Japanese Dental Science Review
- Vol. 57, 138-146
Open AccessOuter membrane vesicles of Porphyromonas gingivalis: Novel communication tool and strategy
- 21 August 2021
- Published by Wiley in BioFactors
- Vol. 47 (6) , 992-1015
O‐GlcNAcylation drives calcium signaling toward osteoblast differentiation: A bioinformatics‐oriented study
This study aimed to reveal the possible mechanisms by which O‐linked‐N‐acetylglucosaminylation (O‐GlcNAcylation) regulates osteoblast differentiation using a series of bioinformatics‐oriented experiments. To examine the influence of O‐GlcNAcylation levels on osteoblast differentiation, osteoblastic MC3T3‐E1 cells were treated with O‐GlcNAc transferase (OGT) and O‐GlcNAcase (OGA) inhibitors. Correlations between the levels of O‐GlcNAcylation and the expression of osteogenic markers as well as OGT were evaluated by qPCR and western blotting. The O‐GlcNAcylated proteins assumed to correlate with Runx2 expression were retrieved from several public databases and used for further bioinformatics analysis. Following the findings of the bioinformatics analysis, intracellular calcium ([Ca2+]i) was monitored in the cells treated with OGT and OGA inhibitors using a confocal laser‐scanning microscope (CLS). The interaction effect between O‐GlcNAcylation and [Ca2+]i on osteogenic marker expression was determined using stable OGT knockdown MC3T3‐E1 cells. O‐GlcNAcylation was positively associated with osteoblast differentiation. The time‐course profile of global O‐GlcNAcylated proteins showed a distinctive pattern with different molecular weights during osteoblast differentiation. The expression pattern of several O‐GlcNAcylated proteins was significantly similar to that of Runx2 expression. Bioinformatic analysis of the retrieved Runx2‐related‐O‐GlcNAcylated‐proteins revealed the importance of [Ca2+]i. CLS showed that alteration of O‐GlcNAcylation rapidly changed [Ca2+]i in MC3T3‐E1 cells. O‐GlcNAcylation and [Ca2+]i showed an interaction effect on the expression of osteogenic markers. OGT knockdown disrupted the [Ca2+]i‐induced expression changes of osteogenic markers. O‐GlcNAcylation interacts with [Ca2+]i and elicits osteoblast differentiation by regulating the expression of osteogenic markers.
- 21 August 2021
- Published by Wiley in BioFactors
- Vol. 47 (6) , 992-1015
O‐GlcNAcylation drives calcium signaling toward osteoblast differentiation: A bioinformatics‐oriented study
This study aimed to reveal the possible mechanisms by which O‐linked‐N‐acetylglucosaminylation (O‐GlcNAcylation) regulates osteoblast differentiation using a series of bioinformatics‐oriented experiments. To examine the influence of O‐GlcNAcylation levels on osteoblast differentiation, osteoblastic MC3T3‐E1 cells were treated with O‐GlcNAc transferase (OGT) and O‐GlcNAcase (OGA) inhibitors. Correlations between the levels of O‐GlcNAcylation and the expression of osteogenic markers as well as OGT were evaluated by qPCR and western blotting. The O‐GlcNAcylated proteins assumed to correlate with Runx2 expression were retrieved from several public databases and used for further bioinformatics analysis. Following the findings of the bioinformatics analysis, intracellular calcium ([Ca2+]i) was monitored in the cells treated with OGT and OGA inhibitors using a confocal laser‐scanning microscope (CLS). The interaction effect between O‐GlcNAcylation and [Ca2+]i on osteogenic marker expression was determined using stable OGT knockdown MC3T3‐E1 cells. O‐GlcNAcylation was positively associated with osteoblast differentiation. The time‐course profile of global O‐GlcNAcylated proteins showed a distinctive pattern with different molecular weights during osteoblast differentiation. The expression pattern of several O‐GlcNAcylated proteins was significantly similar to that of Runx2 expression. Bioinformatic analysis of the retrieved Runx2‐related‐O‐GlcNAcylated‐proteins revealed the importance of [Ca2+]i. CLS showed that alteration of O‐GlcNAcylation rapidly changed [Ca2+]i in MC3T3‐E1 cells. O‐GlcNAcylation and [Ca2+]i showed an interaction effect on the expression of osteogenic markers. OGT knockdown disrupted the [Ca2+]i‐induced expression changes of osteogenic markers. O‐GlcNAcylation interacts with [Ca2+]i and elicits osteoblast differentiation by regulating the expression of osteogenic markers.
- 1 October 2020
- Published by Elsevier in Archives of Oral Biology
- Vol. 118, 104841
Outer membrane vesicles derived from Porphyromonas gingivalis induced cell death with disruption of tight junctions in human lung epithelial cells
- 1 October 2020
- Published by Elsevier in Archives of Oral Biology
- Vol. 118, 104841
Outer membrane vesicles derived from Porphyromonas gingivalis induced cell death with disruption of tight junctions in human lung epithelial cells